Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Fallingborg

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Scandinavian Journal of Gastroenterology|May 17, 2016
Touch screens as a tool in patient care in the IBD outpatient clinicLone Larsen, Asbjørn Mohr Drewes, Jan Fallingborg, et al.
The American Journal of Gastroenterology|August 28, 2013
Cancer risk in inflammatory bowel disease according to patient phenotype and treatment: a Danish population-based cohort studyTine Jess, Erzsébet Horváth-Puhó, Jan Fallingborg, et al.
Therapeutic Advances in Gastroenterology|December 5, 2025
The effect of proton-pump inhibitor therapy on disease outcomes in inflammatory bowel disease: a population-based cohort studyThomas Deleuran, Gry Juul Poulsen, Lone Larsen, et al.
European Journal of Gastroenterology & Hepatology|September 8, 2006
Budesonide treatment and expression of inducible nitric oxide synthase mRNA in colonic mucosa in collagenous colitisOle K Bonderup, Jesper B Hansen, Poul Madsen, et al.
International Journal of Medical Informatics|June 8, 2026
Digitally supported, patient-initiated care: Maintaining control of inflammatory bowel diseases while achieving high patient satisfactionMette Esbjørn, Tina Okdahl, Jan Fallingborg, et al.
European Journal of Gastroenterology & Hepatology|May 17, 2019
Premedication with corticosteroids does not impact the pharmacokinetics of infliximab in inflammatory bowel disease irrespective of azathioprine cotreatmentLone Larsen, Tine Jess, Asbjørn M Drewes, et al.
Danish Medical Journal|June 8, 2013
Biologic therapy in inflammatory bowel diseaseKlaus Theede, Jens Frederik Dahlerup, Jan Fallingborg, et al.
Inflammatory Bowel Diseases|January 24, 2018
Changing Infliximab Prescription Patterns in Inflammatory Bowel Disease: A Population-Based Cohort Study, 1999-2014Lone Larsen, Asbjørn Mohr Drewes, Marie Christine Hede Broberg, et al.
The American Journal of Gastroenterology|February 2, 2023
Has the Incidence of Inflammatory Bowel Disease Peaked? Evidence From the Population-Based NorDIBD Cohort 1978-2020Lone Larsen, Anastasia Karachalia Sandri, Jan Fallingborg, et al.
Gastroenterology Research and Practice|December 8, 2017
The NIMO Scandinavian Study: A Prospective Observational Study of Iron Isomaltoside Treatment in Patients with Iron DeficiencySvein Oskar Frigstad, Anne Haaber, Antal Bajor, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Scandinavian Journal of Gastroenterology|May 17, 2016
Touch screens as a tool in patient care in the IBD outpatient clinicLone Larsen, Asbjørn Mohr Drewes, Jan Fallingborg, et al.
The American Journal of Gastroenterology|August 28, 2013
Cancer risk in inflammatory bowel disease according to patient phenotype and treatment: a Danish population-based cohort studyTine Jess, Erzsébet Horváth-Puhó, Jan Fallingborg, et al.
Therapeutic Advances in Gastroenterology|December 5, 2025
The effect of proton-pump inhibitor therapy on disease outcomes in inflammatory bowel disease: a population-based cohort studyThomas Deleuran, Gry Juul Poulsen, Lone Larsen, et al.
European Journal of Gastroenterology & Hepatology|September 8, 2006
Budesonide treatment and expression of inducible nitric oxide synthase mRNA in colonic mucosa in collagenous colitisOle K Bonderup, Jesper B Hansen, Poul Madsen, et al.
International Journal of Medical Informatics|June 8, 2026
Digitally supported, patient-initiated care: Maintaining control of inflammatory bowel diseases while achieving high patient satisfactionMette Esbjørn, Tina Okdahl, Jan Fallingborg, et al.
European Journal of Gastroenterology & Hepatology|May 17, 2019
Premedication with corticosteroids does not impact the pharmacokinetics of infliximab in inflammatory bowel disease irrespective of azathioprine cotreatmentLone Larsen, Tine Jess, Asbjørn M Drewes, et al.
Danish Medical Journal|June 8, 2013
Biologic therapy in inflammatory bowel diseaseKlaus Theede, Jens Frederik Dahlerup, Jan Fallingborg, et al.
Inflammatory Bowel Diseases|January 24, 2018
Changing Infliximab Prescription Patterns in Inflammatory Bowel Disease: A Population-Based Cohort Study, 1999-2014Lone Larsen, Asbjørn Mohr Drewes, Marie Christine Hede Broberg, et al.
The American Journal of Gastroenterology|February 2, 2023
Has the Incidence of Inflammatory Bowel Disease Peaked? Evidence From the Population-Based NorDIBD Cohort 1978-2020Lone Larsen, Anastasia Karachalia Sandri, Jan Fallingborg, et al.
Gastroenterology Research and Practice|December 8, 2017
The NIMO Scandinavian Study: A Prospective Observational Study of Iron Isomaltoside Treatment in Patients with Iron DeficiencySvein Oskar Frigstad, Anne Haaber, Antal Bajor, et al.
Pageof 2